Cargando…
Targeting Angiotensinogen With N-Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure
Blood pressure management involves antihypertensive therapies blocking the renin-angiotensin system (RAS). Yet, it might be inadequate due to poor patient adherence or the so-called RAS escape phenomenon, elicited by the compensatory renin elevation upon RAS blockade. Recently, evidence points towar...
Autores principales: | Ye, Dien, Cruz-López, Edwyn O., Tu, Ho-Chou, Zlatev, Ivan, Danser, A.H. Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659251/ https://www.ncbi.nlm.nih.gov/pubmed/37855126 http://dx.doi.org/10.1161/ATVBAHA.123.319897 |
Ejemplares similares
-
Angiotensinogen Suppression: A New Tool to Treat Cardiovascular and Renal Disease
por: Cruz-López, Edwyn O., et al.
Publicado: (2022) -
Macrophages in Atherosclerosis Regression
por: Barrett, Tessa J.
Publicado: (2020) -
Heterogeneity of T Cells in Atherosclerosis Defined by Single-Cell RNA-Sequencing and Cytometry by Time of Flight
por: Winkels, Holger, et al.
Publicado: (2020) -
Measuring Arterial Stiffness in Animal Experimental Studies
por: Butlin, Mark, et al.
Publicado: (2020) -
Plasma Pharmacokinetics of N-Acetylgalactosamine-Conjugated Small-Interfering Ribonucleic Acids (GalNAc-Conjugated siRNAs)
por: Sten, Sebastian, et al.
Publicado: (2023)